1174 related articles for article (PubMed ID: 18075407)
1. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
2. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
3. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.
Mercadante S; Arcuri E; Ferrera P; Villari P; Mangione S
J Pain Symptom Manage; 2005 Nov; 30(5):485-91. PubMed ID: 16310622
[TBL] [Abstract][Full Text] [Related]
4. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
[TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of severe cancer pain via spinal catheters].
Andersen JS; Markers PI; Valentin N
Ugeskr Laeger; 1996 Nov; 158(46):6613-6. PubMed ID: 8966828
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
[TBL] [Abstract][Full Text] [Related]
8. Outcome of intrathecal opioids in chronic non-cancer pain.
Roberts LJ; Finch PM; Goucke CR; Price LM
Eur J Pain; 2001; 5(4):353-61. PubMed ID: 11743701
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
[TBL] [Abstract][Full Text] [Related]
10. [Management of intractable cancer pain: from intrathecal morphine to cell allograft].
Lazorthes Y; Sallerin B; Verdie JC; Sol JC; Duplan H; Tkaczuk J; Tafani M; Bastide R; Bes JC
Neurochirurgie; 2000 Nov; 46(5):454-65. PubMed ID: 11084478
[TBL] [Abstract][Full Text] [Related]
11. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
12. Combined intrathecal and epidural magnesium sulfate supplementation of spinal anesthesia to reduce post-operative analgesic requirements: a prospective, randomized, double-blind, controlled trial in patients undergoing major orthopedic surgery.
Arcioni R; Palmisani S; Tigano S; Santorsola C; Sauli V; Romanò S; Mercieri M; Masciangelo R; De Blasi RA; Pinto G
Acta Anaesthesiol Scand; 2007 Apr; 51(4):482-9. PubMed ID: 17378788
[TBL] [Abstract][Full Text] [Related]
13. Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion.
Mercadante S; Villari P; Ferrera P; Casuccio A; Fulfaro F
Cancer; 2002 Jul; 95(1):203-8. PubMed ID: 12115334
[TBL] [Abstract][Full Text] [Related]
14. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients.
Veizi IE; Hayek SM; Narouze S; Pope JE; Mekhail N
Pain Med; 2011 Oct; 12(10):1481-9. PubMed ID: 21943351
[TBL] [Abstract][Full Text] [Related]
15. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
Kiehelä L; Hamunen K; Heiskanen T
Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal morphine in anesthesia for cesarean delivery: dose-response relationship for combinations of low-dose intrathecal morphine and spinal bupivacaine.
Girgin NK; Gurbet A; Turker G; Aksu H; Gulhan N
J Clin Anesth; 2008 May; 20(3):180-5. PubMed ID: 18502360
[TBL] [Abstract][Full Text] [Related]
17. [Continuous intrathecal analgesia in terminal cancer patients within transmural health care].
Wagemans MF; Spoelder EM; Zuurmond WW; de Lange JJ
Ned Tijdschr Geneeskd; 1993 Jul; 137(31):1553-7. PubMed ID: 7690112
[TBL] [Abstract][Full Text] [Related]
18. Priapism--a rare complication following continuous epidural morphine and bupivacaine infusion.
Ruan X; Couch JP; Shah RV; Liu H; Wang F; Chiravuri S
Pain Physician; 2007 Sep; 10(5):707-11. PubMed ID: 17876369
[TBL] [Abstract][Full Text] [Related]
19. Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF.
Wong CS; Chang YC; Yeh CC; Huang GS; Cherng CH
Can J Anaesth; 2002; 49(6):561-5. PubMed ID: 12067866
[TBL] [Abstract][Full Text] [Related]
20. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
